+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Female Infertility Diagnosis & Treatment Market by Product (Accessories, Equipment, Media), Treatment (Assisted Reproductive Technology, Medication, Surgery), Diagnosis, Cause of Infertility, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977741
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Female Infertility Diagnosis & Treatment Market grew from USD 1.81 billion in 2023 to USD 1.96 billion in 2024. It is expected to continue growing at a CAGR of 8.11%, reaching USD 3.14 billion by 2030.

It integrates diagnostic and therapeutic solutions, from hormonal assessments and imaging tests to advanced assisted reproductive technologies (ART), including in vitro fertilization (IVF) and surgical interventions. Increased infertility rates in females due to changes in lifestyle factors, such as higher age of first-time mothers, rising obesity rates, and associated health conditions, including PCOS, are raising the need for female infertility diagnosis & treatments. Moreover, growing awareness about fertility issues and greater social acceptance for seeking treatment support market growth. However, the high cost of ART and other infertility treatment limits patients to adopt female infertility diagnoses and treatments. Furthermore, the integration of AI and machine learning in female infertility diagnosis & treatment improves diagnostic accuracy and predict treatment outcomes, enhancing overall treatment efficacy and supporting future growth.

Regional Insights

In the Americas, high consumer awareness, robust healthcare infrastructure, and favorable government policies drive a strong need for infertility treatments. The countries, notably the United States and Canada, are at the forefront of adopting personalized medicine approaches and investing heavily in related research, thus pushing the envelope in innovative treatment options. The South American market for female infertility diagnosis & treatment is undergoing notable development, driven by enhanced awareness and the increasing availability of medical interventions. Europe, with its robust healthcare systems and regulations, ensures high patient care and data safety standards, fostering a reliable environment for infertility treatments. In the Middle East and Africa, growing healthcare investments and enhancing facilities and services related to infertility treatments drive market growth. The Asia Pacific region is a hub for medical tourism due to cost-effective treatments and rising healthcare standards. In China and India, consumer needs are driven by cost, cultural acceptance, and technology availability. Urban areas in these countries show a higher propensity for adopting advanced medical treatments due to higher income levels and better awareness.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Female Infertility Diagnosis & Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of reproductive and fertility issues among women
  • Government initiatives to promote access to reproductive healthcare solutions
  • Expansion of fertility clinics across the world and expanding awareness about reproductive issues

Market Restraints

  • Lack of skilled personnel and complexity of identifying and treating fertility issues

Market Opportunities

  • Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
  • Favorable regulatory support for new innovations and solutions for managing reproductive issues

Market Challenges

  • Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions

Market Segmentation Analysis

  • Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
  • End User: Fertility clinics' first-line choice for specialized reproductive care

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Female Infertility Diagnosis & Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Female Infertility Diagnosis & Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Lupin Introduces New Generic Infertility Treatment in the U.S. Market

Lupin Limited announced the U.S. launch of its Ganirelix Acetate Injection, 250 mcg/0.5 mL, in a Single-Dose Prefilled Syringe, following the United States Food and Drug Administration (FDA) approval. This product is the generic version of Organon USA LLC's Ganirelix Acetate Injection and is designed to prevent premature luteinizing hormone rise in women undergoing controlled ovarian hyperstimulation.

Arva Health's Innovative At-Home Fertility Test for Indian Women

Arva Health introduced an at-home fertility test developed with leading fertility experts. This test uniquely measures up to 12 hormonal levels pertinent to fertility, allowing women to conveniently assess their reproductive health from home. This is both cost-effective and non-intrusive compared to traditional clinic visits. Arva Health illuminates aspects of the biological clock and potential reproductive issues and equips women with the knowledge to manage their fertility journey proactively at their convenience and discretion.

Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe

Trajan Scientific and Medical partnered with Fertility to launch Europe's first-at-home fertility test kits. These kits incorporate advanced dried blood microsampling technology. Fertilly's move, supported by Trajan Scientific's innovative technologies, represents a crucial step towards democratizing fertility assessments and enabling more informed decisions regarding family planning.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Female Infertility Diagnosis & Treatment Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Female Infertility Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Cook Group Incorporated, CooperSurgical Inc., Ferring B.V., FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation, Genea Pty Limited, GlaxoSmithKline PLC, Halotech DNA S.L., Intas Pharmaceuticals Ltd., Lupin Limited, Merck & Co., Inc., Novartis AG, Sanofi SA, SCSA Diagnostics, Inc., Theramex by Kanga Health Ltd, and Vitrolife Sweden AB.

Market Segmentation & Coverage

This research report categorizes the Female Infertility Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Accessories
  • Equipment
  • Media

Treatment

  • Assisted Reproductive Technology
  • Medication
  • Surgery

Diagnosis

  • Hysteroscopy
  • Imaging Tests
  • Ovulation Testing

Cause of Infertility

  • Endometriosis
  • Ovulatory Disorders
  • Tubal Occlusion

End User

  • Fertility Clinics
  • Hospitals
  • Research Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of reproductive and fertility issues among women
5.1.1.2. Government initiatives to promote access to reproductive healthcare solutions
5.1.1.3. Expansion of fertility clinics across the world and expanding awareness about reproductive issues
5.1.2. Restraints
5.1.2.1. Lack of skilled personnel and complexity of identifying and treating fertility issues
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the effectiveness and accuracy of female infertility diagnosis and treatment solutions
5.1.3.2. Favorable regulatory support for new innovations and solutions for managing reproductive issues
5.1.4. Challenges
5.1.4.1. Concerns related to the accuracy and side effects of female infertility diagnosis and treatment solutions
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing incorporation of media solutions as it support the growth and viability of embryos outside the body
5.2.2. End User: Fertility clinics' first-line choice for specialized reproductive care
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Female Infertility Diagnosis & Treatment Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Equipment
6.4. Media
7. Female Infertility Diagnosis & Treatment Market, by Treatment
7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
7.4. Surgery
8. Female Infertility Diagnosis & Treatment Market, by Diagnosis
8.1. Introduction
8.2. Hysteroscopy
8.3. Imaging Tests
8.4. Ovulation Testing
9. Female Infertility Diagnosis & Treatment Market, by Cause of Infertility
9.1. Introduction
9.2. Endometriosis
9.3. Ovulatory Disorders
9.4. Tubal Occlusion
10. Female Infertility Diagnosis & Treatment Market, by End User
10.1. Introduction
10.2. Fertility Clinics
10.3. Hospitals
10.4. Research Institutes
11. Americas Female Infertility Diagnosis & Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Female Infertility Diagnosis & Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Lupin Introduces New Generic Infertility Treatment in the U.S. Market
14.3.2. Arva Health's Innovative At-Home Fertility Test for Indian Women
14.3.3. Trajan Scientific and German Startup Fertilly Introduce Microsampling-based Fertility Test Kits in Europe
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2030 (%)
FIGURE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL OCCLUSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 82. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 83. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 84. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 85. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 86. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 87. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 92. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 93. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 94. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 95. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 96. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 97. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 136. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 137. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 138. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 139. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 140. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 141. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 142. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 143. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 146. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 147. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 148. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 149. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 150. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 151. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. INDIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 166. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 167. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 168. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 169. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 170. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 171. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. JAPAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 223. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 226. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 227. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 228. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 229. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 230. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 231. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 232. THAILAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 255. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 258. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 259. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 260. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 261. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 262. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 264. DENMARK FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 265. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 268. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 269. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 270. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 271. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 272. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 273. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 274. EGYPT FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 275. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 278. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 279. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 280. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 281. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2018-2023 (USD MILLION)
TABLE 282. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CAUSE OF INFERTILITY, 2024-2030 (USD MILLION)
TABLE 283. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. FINLAND FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. FRANCE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLIO

Companies Mentioned

The leading players in the Female Infertility Diagnosis & Treatment market, which are profiled in this report, include:
  • Bayer AG
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • Ferring B.V.
  • FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
  • Genea Pty Limited
  • GlaxoSmithKline PLC
  • Halotech DNA S.L.
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi SA
  • SCSA Diagnostics, Inc.
  • Theramex by Kanga Health Ltd
  • Vitrolife Sweden AB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.14 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Female Infertility Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Female Infertility Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 109 Pages
  • Global
From
Female Infertility - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Female Infertility - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 129 Pages
  • Global
From
Female Infertility: Seven-Market Drug Forecast and Market Analysis - Product Image

Female Infertility: Seven-Market Drug Forecast and Market Analysis

  • Report
  • 112 Pages
  • Global
From
Female Infertility - Pipeline Insight, 2024 - Product Image

Female Infertility - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.